<- Go Home

Moringa Acquisition Corp

As of August 15, 2024, Moringa Acquisition Corp was acquired by Silexion Therapeutics LTD, in a reverse merger transaction. Moringa Acquisition Corp does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. It focuses on acquiring technology-based companies in Israel. The company was incorporated in 2020 and is based in New York, New York.

Market Cap

$32.6M

Volume

9.1K

Cash and Equivalents

$17.9K

EBITDA

N/A

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

N/A

Profit Margin

N/A

52 Week High

$13.56

52 Week Low

$8.64

Dividend

N/A

Price / Book Value

-10.81

Price / Earnings

-70.06

Price / Tangible Book Value

-10.81

Enterprise Value

$35.9M

Enterprise Value / EBITDA

N/A

Operating Income

-$971.6K

Return on Equity

18.79%

Return on Assets

-3.63

Cash and Short Term Investments

$17.9K

Debt

$3.3M

Equity

-$3.4M

Revenue

N/A

Unlevered FCF

$20.8M

Sector

Capital Markets

Category

N/A

Company Stock Pitches